Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 56.58B P/E 16.44 EPS this Y - Ern Qtrly Grth 118.80%
Income -2.94B Forward P/E - EPS next Y - 50D Avg Chg 1.00%
Sales 47.64B PEG - EPS past 5Y - 200D Avg Chg -2.00%
Dividend 4.00% Price/Book 1.37 EPS next 5Y - 52W High Chg -16.00%
Recommedations - Quick Ratio 0.78 Shares Outstanding 0.98B 52W Low Chg 24.00%
Insider Own 0.03% ROA 4.04% Shares Float 0.98B Beta 0.97
Inst Own 48.14% ROE -8.17% Shares Shorted/Prior -/- Price 57.06
Gross Margin 58.55% Profit Margin -6.17% Avg. Volume 6,419 Target Price -
Oper. Margin 79.04% Earnings Date - Volume 236 Change -2.10%
About BAYER AG

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

BAYER AG News
08:11 AM Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
05:50 AM Pharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive
04/13/24 How Roundup lawsuits could give China an edge
04/11/24 Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion
04/09/24 Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
04/08/24 Here’s Why Bayer Aktiengesellschaft (BAYRY) Detracted in Q1
04/05/24 Judge slashes Bayer $1.56 billion Roundup verdict to $611 million
04/05/24 Bayer’s $1.5 Billion Roundup Verdict Slashed to $600 Million
03/28/24 Bayer-Backed Boundless Bio Falls 11% After $100 Million IPO
03/27/24 Bayer-Backed Drug Maker Boundless Bio Raises $100 Million in IPO
03/25/24 Bayer (BAYRY) Banks on Pipeline Progress Amid Challenges
03/22/24 Thermo Fisher (TMO) Inks Deal to Develop Companion Diagnostics
03/21/24 One CEO’s Radical Fix for Corporate Troubles: Purge the Bosses
03/21/24 New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding
03/21/24 Bayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
03/21/24 Bayer streamlines pharma leadership team amid company shakeup
03/20/24 Bayer's (BAYRY) Elinzanetant Meets Goals in Third Phase III Study
03/19/24 With new data, Bayer readies rival to Astellas menopause drug
03/14/24 Bayer CEO: Now is not the time to break the company up
03/13/24 Inflation: Over-the-counter drug prices leap year over year